NO20080158L - Oyedraper som inneholder roflumilast - Google Patents

Oyedraper som inneholder roflumilast

Info

Publication number
NO20080158L
NO20080158L NO20080158A NO20080158A NO20080158L NO 20080158 L NO20080158 L NO 20080158L NO 20080158 A NO20080158 A NO 20080158A NO 20080158 A NO20080158 A NO 20080158A NO 20080158 L NO20080158 L NO 20080158L
Authority
NO
Norway
Prior art keywords
roflumilast
oyadraper
containing roflumilast
efficiency
increased
Prior art date
Application number
NO20080158A
Other languages
English (en)
Inventor
Yoko Endo
Aiko Kimura
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of NO20080158L publication Critical patent/NO20080158L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Det tilveiebringes øyedråper inneholdende roflumilast som aktiv bestanddel med økt effektivitet. Ved innføring av minst en type viskositetsøkende middel i øyedråpen inneholdende roflumilast som en effektiv bestanddel, kan det fremstilles en øyedråpe der effektiviteten for roflumilast er økt.
NO20080158A 2005-06-09 2008-01-09 Oyedraper som inneholder roflumilast NO20080158L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005169015 2005-06-09
PCT/JP2006/311576 WO2006132342A1 (ja) 2005-06-09 2006-06-09 ロフルミラスト点眼液

Publications (1)

Publication Number Publication Date
NO20080158L true NO20080158L (no) 2008-03-04

Family

ID=37498536

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080158A NO20080158L (no) 2005-06-09 2008-01-09 Oyedraper som inneholder roflumilast

Country Status (8)

Country Link
US (1) US20090209599A1 (no)
EP (1) EP1889620A4 (no)
KR (1) KR20080029974A (no)
CN (1) CN101193634A (no)
CA (1) CA2610881A1 (no)
NO (1) NO20080158L (no)
RU (1) RU2007149249A (no)
WO (1) WO2006132342A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103269686B (zh) * 2010-12-17 2015-08-05 日本乐敦制药株式会社 隐形眼镜用眼科组合物
CN102793684B (zh) * 2011-05-26 2016-02-17 杭州赛利药物研究所有限公司 罗氟司特液体制剂及其制备方法
EP2730292A4 (en) * 2011-07-08 2015-01-14 Rohto Pharma AQUEOUS OPHTHALMIC COMPOSITION
JP6462201B2 (ja) * 2012-06-14 2019-01-30 ロート製薬株式会社 水性眼科組成物
JP5988855B2 (ja) 2012-06-27 2016-09-07 ロート製薬株式会社 水性眼科組成物
CA2914472C (en) * 2012-08-24 2019-09-03 Ashim K. Mitra Ophthalmic formulation of polyoxyl lipid or polyoxyl fatty acid and treatment of ocular conditions
ES2974821T3 (es) 2015-11-10 2024-07-01 Sun Pharmaceutical Ind Ltd Formulaciones tópicas y usos de las mismas
BR112018067946A8 (pt) 2016-02-29 2022-11-08 Sun Pharma Global Fze Formulações tópicas contendo ciclosporina e usos das mesmas
JP2024501425A (ja) * 2020-12-03 2024-01-12 サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド 眼炎症の有害作用を軽減するためのジフルプレドナート
CN116867480A (zh) * 2021-02-10 2023-10-10 洛利克斯治疗有限公司 眼部递送罗氟司特的方法
EP4405048A1 (en) * 2021-09-22 2024-07-31 Iolyx Therapeutics, Inc. Methods of treating ocular inflammatory diseases
WO2024059241A1 (en) * 2022-09-16 2024-03-21 Iolyx Therapeutics, Inc. High concentration pharmaceutical compositions of roflumilast for ophthalmic delivery

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5500230A (en) * 1987-01-23 1996-03-19 The General Hospital Corporation Method for treatment of glaucoma with nitrogen containing guanylate cyclase activators
DK0642332T3 (da) * 1992-05-13 1997-06-16 Sandoz Ltd Ophthalmiske præparater indeholdende cyclosporin
ATE217612T1 (de) * 1993-07-02 2002-06-15 Byk Gulden Lomberg Chem Fab Fluoralkoxy substituierte benzamide und ihre verwendung als zyklisch-nukleotid phosphodiesterase-inhibitoren
ES2228512T3 (es) * 1999-05-04 2005-04-16 Altana Pharma Ag Combinacion sinergica que comprende roflumilast y un inhibidor de pde-3.
PT1511481E (pt) * 2002-05-28 2011-01-14 Nycomed Gmbh Utilização oftalmológica de roflumilast para o tratamento de doenças do olho

Also Published As

Publication number Publication date
RU2007149249A (ru) 2009-07-20
WO2006132342A1 (ja) 2006-12-14
CN101193634A (zh) 2008-06-04
EP1889620A4 (en) 2008-12-10
EP1889620A1 (en) 2008-02-20
CA2610881A1 (en) 2006-12-14
KR20080029974A (ko) 2008-04-03
US20090209599A1 (en) 2009-08-20

Similar Documents

Publication Publication Date Title
NO20080158L (no) Oyedraper som inneholder roflumilast
NO20083630L (no) Nye pyridinderivater
NO20091395L (no) Nye tiofenderivater
NO20075298L (no) Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
EA201390885A1 (ru) Азаиндолы в качестве противовирусных агентов против респираторного синцитиального вируса
NO20083462L (no) Nye tiofenderivater som S1P1/EDG1-reseptoragonister
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
CL2009000393A1 (es) Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular.
WO2008110308A3 (en) Novel herbicides
MX2009009290A (es) Compuestos activos en ppar.
NO20076648L (no) Novel thiophene derivatives
WO2015038939A3 (en) Modulators of complement factor b
WO2009137391A3 (en) Benzene sulfonamide thiazole and oxazole compounds
UY33397A (es) Forma sólida de un naftaleno carboxamida
TW200942524A (en) Novel aminomethyl benzene derivatives
NO20071549L (no) Nye benzofuserte heteroalrylsulfamidderivater, anvendelige som anti-krampemidler
EA200701845A1 (ru) Рофлумиласт для лечения сахарного диабета
EA201170132A1 (ru) 5-гетероциклилалкил-3-гидрокси-2-фенилциклопент-2-еноны в качестве гербицидов
WO2007101864A3 (en) Compounds that modulate ppar activity, their preparation and use
TW200740429A (en) Methods and dosage forms for reducing side effects of carbamate compounds
WO2007081878A3 (en) Indoleamine 2,3-dioxygenase pathways in the generation of regulatory t cells
UA106880C2 (uk) Нові гербіциди
WO2011143772A9 (en) Inhibitors of hiv replication
WO2008151828A3 (en) Novel microbiocides
WO2009127718A3 (en) Novel microbiocides

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application